Company profile for ARMGO Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Some see a disease and search for solutions. We explore the mechanisms that cause diseases, identify the targets, and develop novel small molecules that restore normal function. The ARMGO approach uses fundamental scientific discovery to open new doors to the treatment of debilitating disorders—a process that has led to the discovery of our unprecedented Rycal therapeutics. ARMGO links scientific discovery to the development...
Some see a disease and search for solutions. We explore the mechanisms that cause diseases, identify the targets, and develop novel small molecules that restore normal function. The ARMGO approach uses fundamental scientific discovery to open new doors to the treatment of debilitating disorders—a process that has led to the discovery of our unprecedented Rycal therapeutics. ARMGO links scientific discovery to the development of new therapeutics that can benefit patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
777 Old Saw Mill River Road, Tarrytown, NY 10591
Telephone
Telephone
914-425-0000
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/marketing/letting-go-armgo-biotech-rebrands-rycarma-therapeutics

FIERCE PHARMA
07 Jan 2025

https://www.businesswire.com/news/home/20230719569965/en

BUSINESSWIRE
19 Jul 2023
Armgo bags $35M for phase 2 heart rhythm study
Armgo bags $35M for phase 2 heart rhythm study

21 Dec 2021

// N.P. Taylor FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/forbion-arms-biotech-to-stop-sudden-cardiac-death-leading-35m-round-to-fund-phase-2-trial

N.P. Taylor FIERCEBIOTECH
21 Dec 2021

https://www.globenewswire.com/news-release/2021/12/20/2355102/0/en/ARMGO-Pharma-raises-35-million-to-progress-clinical-studies-of-lead-molecule-ARM210-in-cardiac-and-skeletal-muscle-diseases.html

GLOBENEWSWIRE
20 Dec 2021

https://www.prnewswire.com/news-releases/armgo-pharma-inc-announces-clinical-trial-of-arm210s48168-for-the-treatment-of-ryanodine-receptor-type-1-related-myopathies-300975427.html

PR NEWSWIRE
17 Dec 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty